About IMD Natural Solutions
IMD Natural Solutions is a company based in Dortmund (Germany) founded in 2012 was acquired by LANXESS in April 2018. IMD Natural Solutions has raised $4.47 million across 1 funding round from investors including LANXESS and Zhejiang Hisun Pharmaceuticals. IMD Natural Solutions operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Dortmund, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of IMD Natural Solutions
IMD Natural Solutions has successfully raised a total of $4.47M through 1 strategic funding round. The most recent funding activity was a Series A round of $4.47 million completed in August 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in IMD Natural Solutions
IMD Natural Solutions has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include LANXESS and Zhejiang Hisun Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pharmaceutical APIs, formulations, and animal health products are manufactured.
|
Locked | Locked | Locked | |
|
Chemical company
|
Locked | Locked | Locked |
Investor details for IMD Natural Solutions
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IMD Natural Solutions
Investment portfolio details for IMD Natural Solutions
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - IMD Natural Solutions
Detailed financials for IMD Natural Solutions
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Imd Natural Solutions Comparisons
Peer comparison for IMD Natural Solutions
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IMD Natural Solutions
IMD Natural Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of IMD Natural Solutions
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Imd Natural Solutions
Complete news archive for IMD Natural Solutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IMD Natural Solutions
IMD Natural Solutions was founded in 2012 and raised its 1st funding round 3 years after it was founded.
IMD Natural Solutions is headquartered in Dortmund, Germany. It is registered at Dortmund, North Rhine-westphalia, Germany.
IMD Natural Solutions is a funded company, having raised a total of $4.47M across 1 funding round to date.
IMD Natural Solutions is a chemicals company specializing in chemicals derived from natural sources. The company has multiple natural product libraries derived from a collection of over 40,000 fungal and bacterial species, and approximately 6,000 plant species, algae, and other biological source material. The company provides its compound library in HTS screenable format that can be accessed by companies in various industries for discovery. IMD also has an informatics platform that integrates public and proprietary data into a Natural Product Profile system that can provide biological activity profiles and chemical information on candidates. The company leverages its compound libraries, informatics platform, and its own expertise in the chemistry, biology, pharmacology and toxicology of natural products to deliver commoditized services to clients that include screening, lead discovery, process development and optimization, fermentation, and analytical services.
IMD Natural Solutions's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
IMD Natural Solutions has 2 investors. Key investors include LANXESS, and Zhejiang Hisun Pharmaceuticals.